BioMedSyn

Movmedix, originally founded as L.A.R.S. by Dr. Jacques-Philippe Laboureau in 1992, has established itself as a leader in the artificial ligament market, particularly with its LARS™ (Ligament Advanced Reinforcement System) product range. With a vision to restore infinite mobility to patients suffering from sports injuries, the company has celebrated 30 years of innovation and is evolving to become a global player in the Sports Medicine market. Movmedix is committed to advancing its offerings through cutting-edge science and technology, continuously developing new generations of artificial ligaments, including bioactive and biomimetic options, supported by extensive clinical research. As the company transitions to its new identity, it aims to enhance its service to surgeons and patients alike, ensuring high-quality solutions for active individuals and athletes.